Catheter News and Research

RSS

In medicine, a catheter is a tube that can be inserted into a body cavity, duct, or vessel. Catheters . In most uses, a catheter is a thin, flexible tube ("soft" catheter), though in some uses, it is a larger, solid ("hard") catheter. A catheter left inside the body, either temporarily or permanently, may be referred to as an indwelling catheter. A permanently inserted catheter may be referred to as a permcath.

Researchers to create new type of bioactive coating for brain aneurysm stents

Researchers at Purdue University are working with the U.S. Army and neurosurgeons at the Walter Reed National Military Medical Center to create a new type of "bioactive" coating for stents used to treat brain aneurysms including those caused by head trauma from bomb blasts.

22 May 2012

FDA clears Teleflex’s ARROW PICC with Chloragard technology

Teleflex Incorporated announced today that in addition to broad-spectrum antimicrobial protection, the pressure-injectable ARROW PICC with Chloragard Technology provides antithrombogenic protection for at least 30 days.

22 May 2012

$Children with pelvic and thigh fractures rarely develop dangerous blood clots$

Children with pelvic and thigh fractures rarely develop dangerous blood clots

Children with pelvic and thigh fractures develop dangerous blood clots so rarely that anti-clotting therapy should be given only to those with underlying conditions that increase clotting risk, according to a study from Johns Hopkins Children's Center.

21 May 2012

CSA Medical unveils new truFreeze Spray Cryotherapy System

CSA Medical, Inc. unveiled the new truFreeze Spray Cryotherapy System this week at the Digestive Disease Week (DDW) 2012 Annual Meeting in San Diego.

21 May 2012

Pantera Lux Paclitaxel Releasing Balloon highly promising for DES restenosis

Six-month results from the DELUX registry demonstrating excellent safety and efficacy results for the Pantera Lux Paclitaxel Releasing Balloon in more than 1000 patients were presented by Ralph Toelg, MD, Segeberger Heart Center Clinic, Germany, and Thomas Schmitz, MD, Elisabeth Hospital, Germany, at the EuroPCR 2012 congress in Paris last week.

21 May 2012

$Anti-clotting drugs rarely needed in children with big-bone fractures$

Anti-clotting drugs rarely needed in children with big-bone fractures

21 May 2012

Final results from C3BS-CQR-1 Phase II trial on heart failure

The Belgian biotechnology company, Cardio3 BioSciences (C3BS), a leader in the discovery and development of regenerative and protective therapies for the treatment of cardiovascular diseases, today announces that the final results of its Phase II clinical trial of C3BS-CQR-1 is will be presented at the late breaking clinical trial session at the European Society of Cardiology 2012 Heart Failure Congress in Belgrade, Serbia taking place on May 19-22.

19 May 2012

Positive results from CardioKinetix Parachute system study on heart failure

CardioKinetix Inc., a medical device company pioneering a catheter-based treatment for heart failure, today announced two-year clinical results for the first-of-its-kind catheter-based Parachute Ventricular Partitioning Device, a Percutaneous Ventricular Restoration (PVR) therapy for patients with ischemic heart failure.

19 May 2012

Covalon to showcase advanced medical coating capabilities at AUA annual meeting

Covalon Technologies Ltd., an advanced medical technologies company, today announced it will be showcasing its advanced medical coating capabilities, including its SilverCoat Antimicrobial Silicone Foley Catheter as well as its recently FDA cleared IV Clear antimicrobial silicone adhesive film dressing from May 19th to May 23rd at the American Urological Association 2012 Annual Meeting in Atlanta, Georgia.

19 May 2012

Some patients mistakenly undergo bypass surgery after diagnostic angiography

Research led by Christiana Care Health System's Andrew Doorey, M.D. has found that a small number of patients mistakenly undergo bypass surgery after diagnostic angiography.

19 May 2012

Specialized high volume centers linked with lower rates of death and disability from aSAH

People with bleeding brain aneurysms have the best chance of survival and full recovery if they receive aggressive emergency treatment from a specialized team at a hospital that treats a large number of patients like them every year, according to new guidelines just published by the American Stroke Association.

19 May 2012

UK-led technologies set to transform treatments on the NHS

Video games, pioneering gene therapies and new medical devices are set to transform treatments on the NHS, with support from the Department of Health and the Wellcome Trust.

19 May 2012

Covidien launches new HALO ablation catheter to treat Barrett's esophagus

Covidien, a leading global provider of healthcare products, today announced the launch of the HALO90 ULTRA Ablation Catheter, the latest addition to the HALO family of catheters for the endoscopic treatment of Barrett's esophagus.

18 May 2012

Cardiac ischemia plays an important role in adenovector gene transfection in mammalian hearts

Cardium Therapeutics today announced a late-breaking poster presentation at the American Society of Gene & Cell Therapy (ASGCT) 15th Annual Meeting being held May 16-19, 2012 at the Pennsylvania Convention Center in Philadelphia, PA.

17 May 2012

PPCI treatment on the rise among Stent for Life Initiative participants

Life saving primary percutaneous coronary intervention (PPCI) treatment is increasing in countries participating in the Stent for Life Initiative.

17 May 2012

NeuroSigma Subsidiary sees potential for Thin-Film Nitinol in next-generation flow-diverting stents for treating intracranial aneurysms

NeuroSigma, Inc., a Los Angeles-based medical device company, today announced that its majority-owned subsidiary, NSVascular, Inc. (NSV), acquired a portfolio of patents and related trade secrets covering the fabrication of Thin-Film Nitinol (TFN) from TiNi Alloy Company, including U.S. Patent No. 6,746,890 entitled “Three Dimensional Thin Film Devices and Methods of Fabrication,” an important piece of the portfolio covering the production of three-dimensional TFN constructs.

16 May 2012

Positive results from Boston Scientific's Lotus Aortic Valve System trial

Boston Scientific Corporation announces results from the REPRISE I feasibility trial, which evaluated the acute safety of the Lotus Aortic Valve System in patients with severe aortic valve disease.

16 May 2012

BiO2 Medical receives CE Mark approval for Angel Catheter to prevent PE

BiO2 Medical, Inc. a Texas based medical device manufacturer with corporate offices in San Antonio, Texas, and R&D and manufacturing operations in Golden, Colorado, announced today that it has received CE Mark approval for the Angel Catheter, a Nitinol Inferior Vena Cava (IVC) filter, permanently attached to a central venous catheter (CVC) for the use of preventing Pulmonary Embolism (PE) in critically ill patients.

16 May 2012

USPTO issues new patent to Excelsior Medical's SwabKIT

Excelsior Medical Corporation announced that the United States Patent and Trademark Office (USPTO) has issued new US Patent No. 8,167,847 to the company. The patent relates to an antiseptic cap and antiseptic cap equipped plunger and syringe barrel assembly.

15 May 2012

Boston Scientific launches Innova Self-Expanding Bare-Metal Stent System in Europe

Boston Scientific Corporation announces CE Mark and European market launch of the Innova Self-Expanding Bare-Metal Stent System, which is designed to treat peripheral vascular lesions in arteries above the knee, specifically the superficial femoral artery (SFA) and proximal popliteal artery (PPA). The company plans to launch the product immediately in Europe and other CE Mark countries.

14 May 2012